Ana I Lopez-Medina

6PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 10, 2026
Association of the NOS1AP rs10494366 Genetic Variant With Drug-Induced QT Prolongation.

|Apr 26, 2025
The Beta-Blocker Pharmacogenetic Puzzle: More Pieces of Evidence for Pharmacodynamic Candidate Variants.

Jasmine A Luzum, Shana D R Littleton, Ana I Lopez-Medina

|Feb 04, 2025
Early Check-In Protocol: Identifying Medication Issues in Patients with Cancer at Health System Specialty Pharmacy.

Kayla Ann Phillips, Andrew Wash, Kristin Hutchinson

|Mar 20, 2024
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study.

Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal

|Jun 14, 2022
The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.

Ana I Lopez-Medina, Choudhary Anwar A Chahal, Jasmine A Luzum

|Sep 02, 2020
QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights.

Ana I Lopez-Medina, Alessandra M Campos-Staffico, Jasmine A Luzum

Pageof 1

Frequent Collaborators

5 joint publications

Jasmine A Luzum

3 joint publications

Choudhary Anwar A Chahal

2 joint publications

Alessandra M Campos-Staffico

1 joint publications

Omer Berenfeld